Antares Pharma Inc (ATRS.OQ)

ATRS.OQ on NASDAQ Stock Exchange Capital Market

2.60USD
18 Dec 2014
Price Change (% chg)

$0.06 (+2.36%)
Prev Close
$2.54
Open
$2.56
Day's High
$2.60
Day's Low
$2.56
Volume
195,244
Avg. Vol
287,182
52-wk High
$5.01
52-wk Low
$1.83

ATRS.OQ

Chart for ATRS.OQ

About

Antares Pharma, Inc. (Antares) is a pharma company that focuses on self-injection pharmaceutical products and technologies and topical gel-based products. The Company’s subcutaneous and intramuscular injection technology platforms include Vibex disposable pressure-assisted auto injectors, Vision reusable needle-free injectors,... (more)

Overall

Beta: 0.44
Market Cap (Mil.): $334.48
Shares Outstanding (Mil.): 131.68
Dividend: --
Yield (%): --

Financials

  ATRS.OQ Industry Sector
P/E (TTM): -- 33.36 37.24
EPS (TTM): -0.24 -- --
ROI: -47.48 10.81 18.21
ROE: -49.43 12.64 19.11
Search Stocks

Alliant reviewing Orbital deal after rocket explosion

- Alliant Techsystems Inc said on Wednesday it was conducting a "thorough evaluation" of an agreement to merge its space and defense business with Orbital Sciences Corp following the explosion of an Orbital unmanned supply rocket.

29 Oct 2014

Orbital options active after rocket explosion

NEW YORK, Oct 29 - Orbital Sciences Corp's options drew a rush of activity as traders placed bearish bets on Wednesday, a day after the rocket maker's unmanned 14-story Antares rocket exploded shortly after lift-off.

29 Oct 2014

Rocket explosion unlikely to hurt ATK-Orbital merger - analyst

Oct 29 - The explosion of Orbital Sciences Corp's Antares rocket upon liftoff on Tuesday should not affect the company's planned merger with Alliant Techsystems Inc , a Jefferies & Co analyst said.

29 Oct 2014

U.S. cargo ship blasts off with supplies for space station

CAPE CANAVERAL Fla - - An unmanned Orbital Sciences Corp Antares rocket blasted off from a seaside launch pad in Virginia on Sunday, sending a Cygnus cargo ship on its way to the International Space Station, a NASA Television broadcast showed. | Video

13 Jul 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: GlobalData
$125.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Jefferson Research
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks